Synthesis, anticancer activity and photophysical properties of novel substituted 2-oxo-2H-chromenylpyrazolecarboxylates. 2013

J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, Andhra Pradesh, India.

2-Oxo-2H-chromenylpyrazolecarboxylates (8a-h and 12a-zb) have been synthesized by [3 + 2] cycloaddition of 2H-chromenophenylhydrazones (7a-h and 11a-w) with diethyl/dimethylbut-2-ynedioates. Phenylchromeno[4,3-c]pyrazol-4(1H)-ones (13i-n) were prepared from corresponding phenylhydrazones (7a-h) with catalytic amount of piperidine in presence of pyridine as a solvent at 100 °C. All the synthesized compounds (8a-h, 12a-zb and 13a-n) were screened for anticancer activity against three human cancer cell lines such as prostate (DU-145), lung adenocarcinoma (A549), and cervical (HeLa) by standard MTT assay method. Further, photophysical properties (UV and fluorescence) for these compounds were discussed.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
January 2012, Scientia pharmaceutica,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
August 2010, Bioorganic & medicinal chemistry letters,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
July 2014, The Journal of organic chemistry,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
January 2013, European journal of medicinal chemistry,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
July 2010, European journal of medicinal chemistry,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
April 1992, Journal of medicinal chemistry,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
November 1999, European journal of medicinal chemistry,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
August 2020, Bioorganic & medicinal chemistry letters,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
January 1990, Acta poloniae pharmaceutica,
J Ashok Kumar, and G Saidachary, and G Mallesham, and B Sridhar, and Nishant Jain, and Shashi Vardhan Kalivendi, and V Jayathirtha Rao, and B China Raju
December 2007, Organic & biomolecular chemistry,
Copied contents to your clipboard!